Entry Detail



General Information

Database ID:exR0089830
RNA Name:hsa-miR-373-3p
RNA Type:miRNA
Chromosome:chr19
Starnd:+
Coordinate:
Start Site(bp):53788748End Site(bp):53788770
External Links:hsa-miR-373-3p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
VLDLR
chr9
2621787
2660056
+
USP24
chr1
55066359
55215364
-
CELF2
chr10
10798397
11336675
+
APP
chr21
25880550
26171128
-
KLHL28
chr14
44924319
45042322
-
RGMA
chr15
93035273
93089204
-
PFN2
chr3
149964904
150050788
-
FAM177A1
chr14
35044907
35113130
+
MBP
chr18
76978827
77133683
-
CUL1
chr7
148697914
148801110
+
MSL1
chr17
40121971
40136917
+
RIT1
chr1
155897808
155911404
-
ATXN1
chr6
16299112
16761491
-
ZFAND4
chr10
45615500
45672780
-
SETD7
chr4
139495941
139606699
-
BAZ1B
chr7
73440406
73522293
-
AMPD2
chr1
109616104
109632053
+
SLC16A14
chr2
230034982
230068993
-
PHC3
chr3
170086732
170181749
-
FAM222B
chr17
28755978
28855232
-
PLEKHM1
chr17
45435900
45490749
-
SYAP1
chrX
16719612
16765340
+
ARL4A
chr7
12686856
12690958
+
RACGAP1
chr12
49976923
50033136
-
LONP2
chr16
48244300
48363122
+
CLIP4
chr2
29097705
29189643
+
ADAR
chr1
154582057
154628013
-
MAGI3
chr1
113390515
113685923
+
NAA16
chr13
41311267
41377030
+
CLOCK
chr4
55427903
55546909
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000943
chr19
47421744
47440665
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC125257.1
chr17
41848518
41851447
-
AL049840.4
chr14
103694516
103695050
-
ARHGAP27P1-BPTFP1-KPNA2P3
chr17
64749663
64781707
-
FGD5-AS1
chr3
14920347
14948424
-
MIR17HG
chr13
91347820
91354579
+
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
SNHG16
chr17
76557764
76565348
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.